Division of Plastic and Reconstructive Surgery, Anschutz Medical Center, University of Colorado, Aurora, Colorado.
J Reconstr Microsurg. 2020 Mar;36(3):197-203. doi: 10.1055/s-0039-1698469. Epub 2019 Oct 7.
Limb salvage in the setting of extremity osteomyelitis, though previously dependent on amputation, has been markedly improved through the application of free tissue flaps. Concern exists as to the utility of the fasciocutaneous flap to combat infection verses the traditional muscle flap. Prior studies have shown success with fasciocutaneous flaps in these patients, but given the small series, the choice remains controversial. The goal of this article was to determine if there is statistical evidence for flap choice in the setting of extremity osteomyelitis.
A systematic review utilizing Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was completed of the current literature pertaining to the treatment of extremity osteomyelitis and flap reconstruction within the MedLine and PubMed databases. Six hundred forty-six studies were reviewed and ultimately 31 were included in the final analysis.
Eight hundred seventy-eight flap reconstructions were identified. Of the 588 muscle flaps, 7.8% ( = 46) had recurrence of osteomyelitis after an average of 36.1 (8.0-111.6) months follow-up. There were seven cases (4.3%) of osteomyelitis recurrence in the 163 fasciocutaneous flap group after an average of 29.8 (18.2-44.6) months follow-up ( = 0.165). Secondary outcomes such as flap loss, hematomas, and infection were analyzed without statistically significant differences between the muscle and fasciocutaneous flap groups.
Selection of flap type is less important than adequate debridement, appropriate antibiotic selection, and sufficient duration of treatment. This study demonstrates that within the literature, fasciocutaneous flaps have a lower recurrence rate of osteomyelitis compared with muscle flaps. As such, fasciocutaneous flaps are appropriate for reconstruction and treatment of extremity osteomyelitis.
在肢体骨髓炎的情况下,虽然以前依赖截肢术,但通过应用游离组织皮瓣显著改善了保肢效果。人们对筋膜皮瓣在抗感染方面相对于传统肌肉瓣的效用存在担忧。先前的研究表明,在这些患者中使用筋膜皮瓣是成功的,但由于小系列研究,选择仍然存在争议。本文的目的是确定在肢体骨髓炎的情况下,选择皮瓣是否有统计学证据。
使用系统评价和荟萃分析(PRISMA)指南对 MedLine 和 PubMed 数据库中有关治疗肢体骨髓炎和皮瓣重建的当前文献进行了系统评价。共回顾了 646 项研究,最终有 31 项研究纳入最终分析。
确定了 878 例皮瓣重建。在 588 例肌肉皮瓣中,7.8%(46 例)在平均 36.1(8.0-111.6)个月的随访后出现骨髓炎复发。在 163 例筋膜皮瓣组中,有 7 例(4.3%)在平均 29.8(18.2-44.6)个月的随访后出现骨髓炎复发(=0.165)。对皮瓣失活、血肿和感染等次要结果进行了分析,肌肉瓣和筋膜皮瓣组之间没有统计学差异。
皮瓣类型的选择不如彻底清创、适当选择抗生素和足够的治疗时间重要。本研究表明,在文献中,筋膜皮瓣的骨髓炎复发率低于肌肉瓣。因此,筋膜皮瓣适用于肢体骨髓炎的重建和治疗。